Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $90.76 USD
Change Today +0.23 / 0.25%
Volume 689.5K
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - clovis oncology inc (CLVS)

Name (Connections)Board RelationshipsTitleKey Developments
Edward McKinley 65 RelationshipsDirector and Chairman of Audit Committee 
Paul Klingenstein 29 RelationshipsDirector and Member of Audit Committee 
Brian Atwood MBA 201 RelationshipsDirector, Member of Audit Committee and Member of Nominating & Corporate Governance Committee 

Compensation Committee* - clovis oncology inc (CLVS)

Name (Connections)Board RelationshipsTitle
Michael Barrett Ph.D. 180 RelationshipsChairman, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
James Blair Ph.D. 164 RelationshipsDirector, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Ginger Graham 105 RelationshipsDirector and Member of Compensation Committee
Thorlef Spickschen Ph.D. 10 RelationshipsDirector and Member of Compensation Committee
CLVS Compensation vs. Industry
544.2K
379.0K
Chief Executive Officer
395.2K
274.6K
Chief Financial Officer
Share price activity for CLOVIS ONCOLOGY INC (CLVS)
52 Week Price Performance
CLVS
Industry Average

Nominating Committee* - clovis oncology inc (CLVS)

Name (Connections)Board RelationshipsTitleKey Developments
Michael Barrett Ph.D. 180 RelationshipsChairman, Chairman of Nominating & Corporate Governance Committee and Member of Compensation CommitteeClovis Oncology, Inc. Adds Ginger Graham and Keith Flaherty to its Board of Directors
06/13/13
James Blair Ph.D. 164 RelationshipsDirector, Chairman of Compensation Committee and Member of Nominating & Corporate Governance CommitteeClovis Oncology, Inc. Announces Resignation of Dr. John C. Reed from the Board of Directors
02/19/13
Brian Atwood MBA 201 RelationshipsDirector, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
Keith Flaherty M.D. 58 RelationshipsDirector and Member of Nominating & Corporate Governance Committee

Corporate Governance Committee* - clovis oncology inc (CLVS)

Name (Connections)Board RelationshipsTitle
Brian Atwood MBA 201 RelationshipsChairman, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Michael Barrett Ph.D. 180 RelationshipsDirector, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
James Blair Ph.D. 164 RelationshipsDirector and Member of Compensation Committee
Keith Flaherty M.D. 58 RelationshipsDirector and Member of Compensation Committee
CLVS and Competitor
Insiders vs. External
Board
11%
89%
Clovis Oncology, Inc.
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLVS:US $90.76 USD +0.23

CLVS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CLVS.
View Industry Companies
 

Industry Analysis

CLVS

Industry Average

Valuation CLVS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 9.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CLOVIS ONCOLOGY INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.